Analysts think VRTX stock price could increase by 18%
Jun 04, 2025, 11:25 AM
2.86%
What does VRTX do
Vertex Pharmaceuticals, headquartered in Boston, specializes in developing small molecule drugs for serious diseases, with four approved cystic fibrosis treatments and therapies for sickle cell disease. The company employs 5,400 people and explores innovative treatments for various conditions, including type 1 diabetes.
30 analysts think VRTX stock price will increase by 17.62%. The current median analyst target is $525.30 compared to a current stock price of $446.59. The lowest analysts target is $333.30 and the highest analyst target is $652.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.